MBX
Price
$17.90
Change
+$0.40 (+2.29%)
Updated
Oct 1 closing price
Capitalization
800.41M
35 days until earnings call
VTYX
Price
$3.54
Change
-$0.06 (-1.67%)
Updated
Oct 2, 11:49 AM (EDT)
Capitalization
256.71M
41 days until earnings call
Interact to see
Advertisement

MBX vs VTYX

Header iconMBX vs VTYX Comparison
Open Charts MBX vs VTYXBanner chart's image
MBX Biosciences
Price$17.90
Change+$0.40 (+2.29%)
Volume$947.1K
Capitalization800.41M
Ventyx Biosciences
Price$3.54
Change-$0.06 (-1.67%)
Volume$1.83K
Capitalization256.71M
MBX vs VTYX Comparison Chart in %
Loading...
MBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MBX vs. VTYX commentary
Oct 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MBX is a StrongBuy and VTYX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 02, 2025
Stock price -- (MBX: $17.90 vs. VTYX: $3.60)
Brand notoriety: MBX and VTYX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MBX: 72% vs. VTYX: 584%
Market capitalization -- MBX: $800.41M vs. VTYX: $256.71M
MBX [@Biotechnology] is valued at $800.41M. VTYX’s [@Biotechnology] market capitalization is $256.71M. The market cap for tickers in the [@Biotechnology] industry ranges from $103.64B to $0. The average market capitalization across the [@Biotechnology] industry is $1.98B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MBX’s FA Score shows that 1 FA rating(s) are green whileVTYX’s FA Score has 1 green FA rating(s).

  • MBX’s FA Score: 1 green, 4 red.
  • VTYX’s FA Score: 1 green, 4 red.
According to our system of comparison, both MBX and VTYX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MBX’s TA Score shows that 6 TA indicator(s) are bullish while VTYX’s TA Score has 5 bullish TA indicator(s).

  • MBX’s TA Score: 6 bullish, 3 bearish.
  • VTYX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, MBX is a better buy in the short-term than VTYX.

Price Growth

MBX (@Biotechnology) experienced а -10.95% price change this week, while VTYX (@Biotechnology) price change was +30.91% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.18%. For the same industry, the average monthly price growth was +12.74%, and the average quarterly price growth was +77.34%.

Reported Earning Dates

MBX is expected to report earnings on Nov 06, 2025.

VTYX is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+4.18% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MBX($800M) has a higher market cap than VTYX($257M). VTYX YTD gains are higher at: 64.384 vs. MBX (-5.046). MBX has higher annual earnings (EBITDA): -86.29M vs. VTYX (-129.1M). MBX has more cash in the bank: 225M vs. VTYX (209M). MBX has less debt than VTYX: MBX (650K) vs VTYX (10.3M). MBX (0) and VTYX (0) have equivalent revenues.
MBXVTYXMBX / VTYX
Capitalization800M257M311%
EBITDA-86.29M-129.1M67%
Gain YTD-5.04664.384-8%
P/E RatioN/AN/A-
Revenue00-
Total Cash225M209M108%
Total Debt650K10.3M6%
TECHNICAL ANALYSIS
Technical Analysis
MBXVTYX
RSI
ODDS (%)
Bearish Trend 3 days ago
75%
Bearish Trend 1 day ago
84%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 1 day ago
85%
MACD
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 1 day ago
85%
Declines
ODDS (%)
Bearish Trend 22 days ago
89%
Bearish Trend 8 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
MBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ADGAX26.41N/A
N/A
AB Core Opportunities A
SLVCX18.26N/A
N/A
Saratoga Large Capitalization Value C
TIERX9.59N/A
N/A
Nuveen International Eq A
JPVZX18.25N/A
N/A
JPMorgan Developed International ValueR2
JRSAX13.20N/A
N/A
JH Adaptive Risk Mgd U.S. Eq A

MBX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MBX has been loosely correlated with KOD. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if MBX jumps, then KOD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MBX
1D Price
Change %
MBX100%
-2.45%
KOD - MBX
45%
Loosely correlated
+3.54%
QLGN - MBX
37%
Loosely correlated
+6.32%
VTGN - MBX
35%
Loosely correlated
+0.28%
VTYX - MBX
33%
Loosely correlated
+2.81%
RARE - MBX
33%
Poorly correlated
-0.92%
More